APA (7th ed.) Citation

Fisk, M., Cheriyan, J., Mohan, D., Forman, J., Mäki-Petäjä, K. M., McEniery, C. M., . . . Wilkinson, I. B. (2018). The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial. PLoS ONE, 13(3), 1. https://doi.org/10.1371/journal.pone.0194197

Chicago Style (17th ed.) Citation

Fisk, Marie, et al. "The P38 Mitogen Activated Protein Kinase Inhibitor Losmapimod in Chronic Obstructive Pulmonary Disease Patients with Systemic Inflammation, Stratified by Fibrinogen: A Randomised Double-blind Placebo-controlled Trial." PLoS ONE 13, no. 3 (2018): 1. https://doi.org/10.1371/journal.pone.0194197.

MLA (9th ed.) Citation

Fisk, Marie, et al. "The P38 Mitogen Activated Protein Kinase Inhibitor Losmapimod in Chronic Obstructive Pulmonary Disease Patients with Systemic Inflammation, Stratified by Fibrinogen: A Randomised Double-blind Placebo-controlled Trial." PLoS ONE, vol. 13, no. 3, 2018, p. 1, https://doi.org/10.1371/journal.pone.0194197.